Home
>
National Drug Code (NDC)
>
Arcalyst
Arcalyst - 61755-001-01 - (rilonacept)
Drug Information of Arcalyst
| Product NDC: | 61755-001 |
| Proprietary Name: | Arcalyst |
| Non Proprietary Name: | rilonacept |
| Active Ingredient(s): | 160 mg/2mL & nbsp; rilonacept |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Arcalyst
| Product NDC: | 61755-001 |
| Labeler Name: | Regeneron Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125249 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20080227 |
Package Information of Arcalyst
| Package NDC: | 61755-001-01 |
| Package Description: | 4 VIAL, SINGLE-USE in 1 CARTON (61755-001-01) > 2 mL in 1 VIAL, SINGLE-USE |
NDC Information of Arcalyst
| NDC Code | 61755-001-01 |
| Proprietary Name | Arcalyst |
| Package Description | 4 VIAL, SINGLE-USE in 1 CARTON (61755-001-01) > 2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 61755-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rilonacept |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20080227 |
| Marketing Category Name | BLA |
| Labeler Name | Regeneron Pharmaceuticals, Inc. |
| Substance Name | RILONACEPT |
| Strength Number | 160 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes |
